Health condition · Clinically reviewed
Rheumatoid arthritis, early diagnosis, DMARDs and biologics.
A chronic autoimmune joint disease that responds well to modern treatment when caught early. Early rheumatology referral changes long-term outcomes.
Why trust this guide
- 01
Clinically reviewed
Written by our editorial team and reviewed by a registered UK clinician before publication.
- 02
Sourced from guidance
Every claim is checked against NICE, EULAR or peer-reviewed sources you can see at the end.
- 03
Current for 2026
Reflects current UK guidance on early DMARDs, biologics and JAK inhibitors.
Key facts
Rheumatoid arthritis at a glance.
The essentials, in plain English - what RA is, how it is diagnosed, and how it is treated in the UK today.
-
Definition
Autoimmune symmetric inflammatory polyarthritis - the immune system attacks the joint lining, causing swelling and, if untreated, joint damage.
-
UK prevalence
Around 1% of UK adults - roughly 400,000 people, and about two to three times more common in women.
-
Anti-CCP antibody
Anti-CCP antibodies are highly specific for RA and often positive years before symptoms - a key diagnostic marker.
-
Early DMARDs
Starting a DMARD within 3 months of symptom onset is transformative - it changes the long-term trajectory of the disease.
-
Biologics and JAKs
When methotrexate is not enough, biologics (anti-TNF, IL-6, rituximab) and JAK inhibitors are added to control disease.
-
Cardiovascular risk
RA raises cardiovascular risk - manage blood pressure, cholesterol and smoking alongside joint disease.
Why this guide matters
Early treatment is everything.
The weeks between symptom onset and starting a DMARD change the long-term trajectory - the earlier the diagnosis, the better the outcome.
-
A window of opportunity
The first 3 months of symptoms are the treatment window - starting a DMARD then transforms outcomes.
-
Modern medicines change lives
Biologics and JAK inhibitors mean remission is a realistic goal for most people today.
-
Whole-person care
Alongside joints, cardiovascular risk, lung health and mood all deserve active management.
How the diagnosis is made
From first swollen joint to a clear plan.
The steps a UK GP and rheumatology team will normally follow, in order - so you know what to expect and why.
Phase 1 · Recognising
Pattern, bloods and initial imaging
Phase 2 · Confirming
Ultrasound or MRI and urgent rheumatology referral
Phase 3 · Baseline
Cardiac and chest workup before biologics
- 01
Recognising
Symptom pattern
More than 6 weeks of symmetric small-joint pain and stiffness - hands, wrists and feet - is the classic pattern.
- 02
Recognising
Bloods
Rheumatoid factor, anti-CCP antibody, CRP and full blood count - anti-CCP is the most specific.
- 03
Recognising
Hand and foot X-ray
Baseline films look for early erosions and joint-space narrowing - often normal early on.
- 04
Confirming
Ultrasound or MRI of the hands
Picks up synovitis and erosions before X-ray changes - useful when the diagnosis is uncertain.
- 05
Confirming
Rheumatology referral within 3 weeks
NICE recommends urgent rheumatology review for suspected inflammatory arthritis - do not wait for bloods.
- 06
Baseline
Baseline echo and CV risk assessment
Cardiovascular risk is elevated in RA - baseline assessment guides prevention.
- 07
Baseline
Baseline chest imaging
Chest X-ray screens for lung involvement and TB before starting biologics or methotrexate.
Typical timeline: 3-6 weeks from first appointment to starting a DMARD.
Symptoms
What rheumatoid arthritis actually feels like.
The pattern is more telling than any single symptom - symmetric small joints, prolonged morning stiffness and a background of systemic fatigue.
-
Symmetric small-joint arthritis
Both hands, both wrists, both feet - the mirror pattern is a hallmark of RA.
-
Morning stiffness over 30 min
Prolonged early-morning stiffness that eases as the day goes on suggests inflammatory arthritis.
-
Joint swelling
Boggy, warm swelling of the knuckles and wrists - not just aching - points to synovitis.
-
Rheumatoid nodules
Firm, painless lumps over pressure points - elbows, tendons - occur in longer-standing disease.
-
Systemic fatigue
Profound tiredness that predates the joint symptoms - a common early feature.
-
Extra-articular disease
Dry eyes, scleritis, pleurisy, nodules - RA can involve tissues beyond the joints.
-
Rheumatoid lung
Interstitial lung disease and pleural effusions occur in a minority - breathlessness needs investigation.
-
Red flag
Fever with a hot swollen joint - rule out septic arthritis. Call 999 or attend A&E the same day.
Treatment
How rheumatoid arthritis is treated in the UK.
A layered approach: DMARDs first, then biologics or JAK inhibitors if disease activity persists - with surgery reserved for refractory joints.
-
Methotrexate
The first-line DMARD - once-weekly, with folic acid. Started early, it changes long-term outcomes.
-
Sulfasalazine and hydroxychloroquine
Used with methotrexate as triple therapy - a cost-effective combination for moderate disease.
-
Leflunomide
An alternative DMARD when methotrexate is not tolerated or contraindicated.
-
Biologics
Adalimumab, etanercept, tocilizumab and rituximab - added when DMARDs alone are insufficient.
-
JAK inhibitors
Tofacitinib and baricitinib - oral small molecules that block intracellular immune signalling.
-
Short-course prednisolone
Used during flares or as a bridge while DMARDs take effect - not for long-term control.
-
Physiotherapy and OT
Movement, joint protection and hand therapy preserve function and reduce disability.
-
Joint surgery
Reserved for refractory joints - synovectomy, tendon repair or joint replacement when medication is not enough.
What this guide is based on
The sources behind every claim on this page.
UK national guidance and specialist society standards, current at the time of last review.
Key references
Guidelines and standards we relied on.
A quiet reminder
This guide is for information, not medical advice.
Your GP or rheumatology team knows your history and can tell you which parts apply to you. If in doubt, get seen.
-
NICE. Rheumatoid arthritis in adults: management (NG100).
-
British Society for Rheumatology. Guidelines library.
-
EULAR. 2023 recommendations for the management of rheumatoid arthritis.
-
Versus Arthritis. Patient information and support.
Red flags
When rheumatoid arthritis becomes an emergency.
RA is usually a slow, chronic disease - but these situations need same-day medical attention.
-
Septic joint
Fever with a hot, swollen, exquisitely tender joint - call 999 or attend A&E the same day.
-
Rheumatoid lung crisis
Sudden breathlessness, cough or chest pain - needs same-day assessment.
-
Vasculitis
New skin ulcers, purpura or nerve symptoms - urgent rheumatology review.
-
Post-biologic infection
Fever, night sweats or new cough on a biologic - screen for TB and PJP; contact your team.
-
Neutropenic sepsis on methotrexate
Fever with a low neutrophil count is a medical emergency - attend A&E immediately.
-
Pregnancy planning
Methotrexate and leflunomide must be stopped before conception - plan ahead with your team.
-
Post-op DVT
Calf swelling or breathlessness after surgery - urgent assessment for clot.
-
Cardiac events
Chest pain or sudden breathlessness - RA raises cardiovascular risk; do not delay.
-
Ocular emergencies
Painful red eye - scleritis and episcleritis need same-day ophthalmology review.
Living with it
A long-term condition, but a very manageable one.
Four things that make the biggest difference day to day - movement, a flare plan, nutrition, and regular reviews.
A quiet reminder
Consistency beats intensity, every time.
Small, steady changes - kept up for months - do more than a heroic week that does not last.
- 01 Movement
Exercise is medicine
Even in painful joints, tailored activity reduces pain and improves function.
- 02 Flares
Have a plan
Know what steps you take when a flare starts - and when to contact your team.
- 03 Nutrition
No magic diet
A Mediterranean-style diet, weight management and oily fish help; supplements have less evidence.
- 04 Reviews
Regular reviews matter
Quarterly disease-activity scores (DAS28) guide treatment changes and drive remission.
Frequently asked
Everything we get asked about rheumatoid arthritis.
Quick answers on diagnosis, anti-CCP, DMARDs, biologics, JAK inhibitors and cardiovascular risk.
-
What is rheumatoid arthritis?
Rheumatoid arthritis is a chronic autoimmune disease in which the immune system attacks the joint lining, causing symmetric small-joint swelling, morning stiffness and, if untreated, joint damage.
-
How is rheumatoid arthritis diagnosed?
By pattern (symmetric small joints, morning stiffness over 30 minutes), blood tests (anti-CCP, rheumatoid factor, CRP) and imaging (hand and foot X-ray, ultrasound or MRI when needed).
-
What is anti-CCP and why does it matter?
Anti-cyclic citrullinated peptide antibody is a blood test that is highly specific for RA and often positive years before symptoms - a strongly positive result makes RA very likely.
-
What are DMARDs?
Disease-modifying anti-rheumatic drugs - methotrexate is the cornerstone. Started within three months of symptom onset, DMARDs prevent joint damage and change the long-term outcome.
-
What are biologics and JAK inhibitors?
Biologics are injected or infused antibodies targeting parts of the immune system (anti-TNF, IL-6, rituximab). JAK inhibitors are tablets that block intracellular immune signalling - both are used when methotrexate is not enough.
-
Why is cardiovascular risk higher in RA?
Chronic inflammation accelerates atherosclerosis. Alongside joint treatment, blood pressure, cholesterol, smoking and weight need active management to reduce heart attack and stroke risk.
Related content
Keep reading.
-
Blood tests
Including anti-CCP, RF and inflammation panels.
Learn more -
Inflammation markers (CRP, ESR)
How CRP and ESR are used in inflammatory disease.
Learn more -
Joint injection
Steroid injections for flares and refractory joints.
Learn more -
All conditions
Browse the full library of patient guides.
Learn more